<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Stock Blog Hub &#187; SIGA</title>
	<atom:link href="http://www.stockbloghub.com/tag/siga/feed" rel="self" type="application/rss+xml" />
	<link>http://www.stockbloghub.com</link>
	<description>Start Your Investing Research Here!</description>
	<lastBuildDate>Thu, 24 May 2012 23:16:35 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.2</generator>
		<item>
		<title>(CMLS) Company News for March 11, 2011 &#8211; Corporate Summary</title>
		<link>http://www.stockbloghub.com/2011/03/11/cmls-company-news-for-march-11-2011-corporate-summary/68582</link>
		<comments>http://www.stockbloghub.com/2011/03/11/cmls-company-news-for-march-11-2011-corporate-summary/68582#comments</comments>
		<pubDate>Fri, 11 Mar 2011 17:45:27 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Broadcasting - Radio]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[CMLS]]></category>
		<category><![CDATA[Cumulus Media Inc.]]></category>
		<category><![CDATA[Glaxosmithkline plc]]></category>
		<category><![CDATA[GMCR]]></category>
		<category><![CDATA[Green Mountain Coffee Roasters Inc]]></category>
		<category><![CDATA[GSK]]></category>
		<category><![CDATA[HGSI]]></category>
		<category><![CDATA[Human Genome Sciences Inc.]]></category>
		<category><![CDATA[IRM]]></category>
		<category><![CDATA[Iron Mountain Inc]]></category>
		<category><![CDATA[LSI]]></category>
		<category><![CDATA[LSI Corporation]]></category>
		<category><![CDATA[National Semiconductor Corporation]]></category>
		<category><![CDATA[NetApp Inc.]]></category>
		<category><![CDATA[NSM]]></category>
		<category><![CDATA[NTAP]]></category>
		<category><![CDATA[SBUX]]></category>
		<category><![CDATA[Semtech Corporation]]></category>
		<category><![CDATA[SIGA]]></category>
		<category><![CDATA[SIGA Technologies Inc]]></category>
		<category><![CDATA[SMTC]]></category>
		<category><![CDATA[Starbucks Corporation]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=68582</guid>
		<description><![CDATA[• Cumulus Media (NASDAQ:CMLS) reported that it has entered into a merger agreement to acquire all the outstanding common stock and warrants of Citadel Broadcasting Corp for $37 per share • Starbucks (NASDAQ:SBUX) and Green Mountain Coffee Roasters (NASDAQ:GMCR) have entered into a strategic relationship for the manufacturing, marketing, distribution and sale of Starbucks and Tazo tea branded K-Cup portion packs for use in the Keurig single-cup brewing system • National Semiconductor (NYSE:NSM) reported Q3 EPS of $0.24, in line with the Zacks Consensus Estimate. Revenues for the quarter fell 12% year-over-year to $343.9 million, lower than the Zacks Consensus Estimate of $352.0 million • Biotech company SIGA Technologies Inc (NASDAQ:SIGA) reported a fourth quarter operating loss of $4.2 million • Late Wednesday NetApp Inc (NASDAQ:NTAP) announced its plans to buy LSI Corporation’s (NYSE:LSI) external ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/03/11/cmls-company-news-for-march-11-2011-corporate-summary/68582/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(SIGA) These Healthcare Stocks Are Ready to Move Next Week</title>
		<link>http://www.stockbloghub.com/2011/01/07/siga-these-healthcare-stocks-are-ready-to-move-next-week/64553</link>
		<comments>http://www.stockbloghub.com/2011/01/07/siga-these-healthcare-stocks-are-ready-to-move-next-week/64553#comments</comments>
		<pubDate>Fri, 07 Jan 2011 18:11:43 +0000</pubDate>
		<dc:creator>InvestmentU</dc:creator>
				<category><![CDATA[Drug Manufacturers - Other]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Athenahealth Inc]]></category>
		<category><![CDATA[ATHN]]></category>
		<category><![CDATA[CGEN]]></category>
		<category><![CDATA[Compugen Limited]]></category>
		<category><![CDATA[DCTH]]></category>
		<category><![CDATA[Delcath Systems Inc.]]></category>
		<category><![CDATA[Eli Lilly & Company]]></category>
		<category><![CDATA[ESRX]]></category>
		<category><![CDATA[Express Scripts Inc.]]></category>
		<category><![CDATA[LLY]]></category>
		<category><![CDATA[MCK]]></category>
		<category><![CDATA[McKesson Corporation]]></category>
		<category><![CDATA[MedcoHealth Solutions Inc.]]></category>
		<category><![CDATA[Merck & Company Inc]]></category>
		<category><![CDATA[MHS]]></category>
		<category><![CDATA[MOH]]></category>
		<category><![CDATA[Molina Healthcare Inc.]]></category>
		<category><![CDATA[MRK]]></category>
		<category><![CDATA[Nektar Therapeutics]]></category>
		<category><![CDATA[NKTR]]></category>
		<category><![CDATA[PFE]]></category>
		<category><![CDATA[Pfizer Inc.]]></category>
		<category><![CDATA[SIGA]]></category>
		<category><![CDATA[SIGA Technologies Inc]]></category>
		<category><![CDATA[TEVA]]></category>
		<category><![CDATA[Teva Pharmaceutical Industries Limited]]></category>
		<category><![CDATA[WellPoint Inc.]]></category>
		<category><![CDATA[WLP]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=64553</guid>
		<description><![CDATA[by Marc Lichtenfeld, Investment U’s Senior Analyst Wednesday, January 5, 2011: Issue #1421 Once again, I’ve secured my golden ticket to the most important healthcare event of the year. In the past, I’ve described the JP Morgan Healthcare Conference as the Super Bowl of the healthcare investing world. That’s no exaggeration either, as industry executives and investors jet in from all over the world to attend. And with hotels, restaurants and even the 37 Starbucks in Union Square packed with people looking for and providing information, even those without an invitation still hit San Francisco just to be near the action. It’s the place to get the latest news on drug development, research funding, and the companies that could be on the cusp of greatness. And for the past few ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/01/07/siga-these-healthcare-stocks-are-ready-to-move-next-week/64553/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(SIGA) Why the Straightforward Approach is Often the Most Profitable</title>
		<link>http://www.stockbloghub.com/2010/04/07/siga-why-the-straightforward-approach-is-often-the-most-profitable/33005</link>
		<comments>http://www.stockbloghub.com/2010/04/07/siga-why-the-straightforward-approach-is-often-the-most-profitable/33005#comments</comments>
		<pubDate>Thu, 08 Apr 2010 00:16:16 +0000</pubDate>
		<dc:creator>InvestmentU</dc:creator>
				<category><![CDATA[Drug Manufacturers - Other]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[INCY]]></category>
		<category><![CDATA[Incyte Corporation]]></category>
		<category><![CDATA[SIGA]]></category>
		<category><![CDATA[SIGA Technologies Inc]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=33005</guid>
		<description><![CDATA[“Don’t be a knucklehead.” This was the sage advice of John Roque, Chief Technical Strategist at WJB Capital in a note to clients earlier this week. He was advising them against trying to short strong markets or buy weak ones. Such a simple, clear message. For years, an abundance of confidence led me to believe that I was so good at picking stocks, I could do it at market tops or bottoms and bag a winner every time. I don’t do that anymore. Although I’m a contrarian investor and often go against the grain, there’s a famous expression on Wall Street: “Don’t try to catch a falling knife.” In other words, don’t fight the prevailing trend. If I believe a stock is set to fall (whether because it’s overvalued, the ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/04/07/siga-why-the-straightforward-approach-is-often-the-most-profitable/33005/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(VNDA) Partial Profit Taking: What To Do When You’re Sitting On Explosive Gains</title>
		<link>http://www.stockbloghub.com/2009/08/07/partial-profit-taking-what-to-do-when-you%e2%80%99re-sitting-on-explosive-gains/12193</link>
		<comments>http://www.stockbloghub.com/2009/08/07/partial-profit-taking-what-to-do-when-you%e2%80%99re-sitting-on-explosive-gains/12193#comments</comments>
		<pubDate>Fri, 07 Aug 2009 22:40:13 +0000</pubDate>
		<dc:creator>InvestmentU</dc:creator>
				<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[SIGA]]></category>
		<category><![CDATA[Siga Technologies]]></category>
		<category><![CDATA[Vanda Pharmaceuticals]]></category>
		<category><![CDATA[VNDA]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=12193</guid>
		<description><![CDATA[by Marc Lichtenfeld, Advisory Panelist Editor’s Note: On August 15, we’ll be expanding our expert list to include Karim Rahemtulla, Lee Lowell and healthcare and biotech expert Marc Lichtenfeld. They’ll be joining our current experts in providing you the best investing ideas and investment education every day. Recently, Marc showed his readers how he locks in his profits in hot biotechs. With a number of small caps exploding upwards over the last few weeks, we felt it’s time to revisit this partial profit taking strategy. So your stock just went way up, now what do you do? We often hear from concerned investors who aren’t sure whether to hold on or sell it all after a huge gain. For example, I’m used to explosive gains in the biotech world, but ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/08/07/partial-profit-taking-what-to-do-when-you%e2%80%99re-sitting-on-explosive-gains/12193/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

